SCHEMBL17667

SCHEMBL17667

O=S(=O)(c1cccs1)N1CCN(c2ccc(C(O)(CF)C(F)F)cc2)[C@@H](CNC2CCOCC2)C1

nearest known ligand 0.61

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCKR Q14397 16/20 0.61
GCK P35557 4/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16727 0.92 GCK (0.56) GCKRGCK
SCHEMBL16527 0.89 GCKR (0.77) GCKRGCK
SCHEMBL16129 0.89 GCKR (0.77) GCKRGCK
SCHEMBL12089640 0.87 GCKR (0.68) GCKRGCK
SCHEMBL18800 0.87 GCKR (0.79) GCKRGCK
SCHEMBL16159 0.87 GCKR (0.79) GCKRGCK
SCHEMBL12077871 0.87 GCKR (0.79) GCKRGCK
SCHEMBL17878 0.86 GCKR (0.77) GCKRGCK
SCHEMBL15200827 0.86 GCKR (0.60) GCKRGCK
SCHEMBL18801 0.85 GCKR (0.59) GCKRGCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed